1. Academic Validation
  2. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma

A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma

  • Nature. 2017 May 18;545(7654):355-359. doi: 10.1038/nature22334.
Tuomas Tammela 1 Francisco J Sanchez-Rivera 1 Naniye Malli Cetinbas 1 Katherine Wu 1 Nikhil S Joshi 1 Katja Helenius 1 Yoona Park 1 Roxana Azimi 1 Natanya R Kerper 1 R Alexander Wesselhoeft 1 Xin Gu 1 Leah Schmidt 1 Milton Cornwall-Brady 1 Ömer H Yilmaz 1 Wen Xue 1 2 Pekka Katajisto 3 4 Arjun Bhutkar 1 Tyler Jacks 1 5
Affiliations

Affiliations

  • 1 David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
  • 2 RNA Therapeutics Institute, Program in Molecular Medicine, and Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.
  • 3 Institute of Biotechnology, University of Helsinki, 00014 Helsinki, Finland.
  • 4 Department of Biosciences and Nutrition, Karolinska Institutet, 14183 Stockholm, Sweden.
  • 5 Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Abstract

The heterogeneity of cellular states in Cancer has been linked to drug resistance, Cancer progression and the presence of Cancer cells with properties of normal tissue stem cells. Secreted Wnt signals maintain stem cells in various epithelial tissues, including in lung development and regeneration. Here we show that mouse and human lung adenocarcinomas display hierarchical features with two distinct subpopulations, one with high Wnt signalling activity and another forming a niche that provides the Wnt ligand. The Wnt responder cells showed increased tumour propagation ability, suggesting that these cells have features of normal tissue stem cells. Genetic perturbation of Wnt production or signalling suppressed tumour progression. Small-molecule inhibitors targeting essential posttranslational modification of Wnt reduced tumour growth and markedly decreased the proliferative potential of lung Cancer cells, leading to improved survival of tumour-bearing mice. These results indicate that strategies for disrupting pathways that maintain stem-like and niche cell phenotypes can translate into effective anti-cancer therapies.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-17545
    99.92%, PORCN Inhibitor